Front Row Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-165
| Closed | -$12.9K | – | 533 |
|
|
2024
Q2 | $12.9K | Buy |
165
+4
| +2% | +$312 | ﹤0.01% | 508 |
|
|
2024
Q1 | $10.9K | Buy |
+161
| New | +$10.9K | ﹤0.01% | 560 |
|
|
2023
Q4 | – | Sell |
-181
| Closed | -$12.3K | – | 504 |
|
|
2023
Q3 | $12.3K | Buy |
181
+12
| +7% | +$813 | 0.01% | 473 |
|
|
2023
Q2 | $12K | Sell |
169
-27
| -14% | -$1.92K | 0.01% | 475 |
|
|
2023
Q1 | $14K | Buy |
196
+6
| +3% | +$429 | 0.01% | 443 |
|
|
2022
Q4 | $13K | Sell |
190
-58
| -23% | -$3.97K | 0.01% | 440 |
|
|
2022
Q3 | $14K | Sell |
248
-218
| -47% | -$12.3K | 0.01% | 440 |
|
|
2022
Q2 | $31K | Sell |
466
-52
| -10% | -$3.46K | 0.02% | 295 |
|
|
2022
Q1 | $34K | Buy |
518
+7
| +1% | +$459 | 0.01% | 307 |
|
|
2021
Q4 | $30K | Sell |
511
-20
| -4% | -$1.17K | 0.01% | 337 |
|
|
2021
Q3 | $32K | Buy |
531
+18
| +4% | +$1.09K | 0.01% | 320 |
|
|
2021
Q2 | $30K | Buy |
513
+228
| +80% | +$13.3K | 0.01% | 336 |
|
|
2021
Q1 | $14K | Buy |
285
+14
| +5% | +$688 | 0.01% | 472 |
|
|
2020
Q4 | $14K | Buy |
271
+11
| +4% | +$568 | 0.01% | 446 |
|
|
2020
Q3 | $14K | Buy |
260
+155
| +148% | +$8.35K | 0.01% | 436 |
|
|
2020
Q2 | $6K | Sell |
105
-5
| -5% | -$286 | ﹤0.01% | 573 |
|
|
2020
Q1 | $6K | Sell |
110
-8
| -7% | -$436 | ﹤0.01% | 562 |
|
|
2019
Q4 | $6K | Buy |
118
+16
| +16% | +$814 | ﹤0.01% | 567 |
|
|
2019
Q3 | $5K | Buy |
102
+50
| +96% | +$2.45K | ﹤0.01% | 578 |
|
|
2019
Q2 | $2K | Buy |
52
+16
| +44% | +$615 | ﹤0.01% | 807 |
|
|
2019
Q1 | $1K | Hold |
36
| – | – | ﹤0.01% | 928 |
|
|
2018
Q4 | $1K | Hold |
36
| – | – | ﹤0.01% | 903 |
|
|
2018
Q3 | $1 | Hold |
36
| – | – | ﹤0.01% | 874 |
|
|
2018
Q2 | $1 | Hold |
36
| – | – | ﹤0.01% | 923 |
|
|
2018
Q1 | $1K | Hold |
36
| – | – | ﹤0.01% | 856 |
|
|
2017
Q4 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 745 |
|